You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cadonilimab

Showing 1 - 25 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023

Cadonilimab in Recurrent or Metastatic Cervical Cancer

Not yet recruiting
  • Recurrent or Metastatic Cervical Cancer
  • Cadonilimab
  • (no location specified)
Nov 23, 2023

Cost-effectiveness Analysis of Cadonilimab in Treatment of

Not yet recruiting
  • Cervical Cancer
  • Cadonilimab
  • (no location specified)
Nov 18, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial (Cadonilimab, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Cadonilimab
  • +3 more
  • (no location specified)
Oct 7, 2023

Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

Not yet recruiting
  • Gastric Adenocarcinoma
  • cadonilimab combined +paclitaxel (albumin-bound)
  • (no location specified)
Nov 1, 2023

Cadonilimab, Clear Cell Renal Cell Carcinoma, Neoadjuvant Therapy Trial in Guangzhou (Cadonilimab Combined With Lenvatinib)

Recruiting
  • Cadonilimab
  • +2 more
  • Cadonilimab Combined With Lenvatinib
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen University Cancer Center
Nov 16, 2023

Hepatocellular Carcinoma Trial in Shanghai (Cadonilimab+TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Jun 21, 2023

Recurrent Glioblastoma Trial (fractionated radiotherapy, cadonilimab)

Not yet recruiting
  • Recurrent Glioblastoma
  • fractionated radiotherapy
  • cadonilimab
  • (no location specified)
Feb 20, 2023

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Immune Checkpoint Inhibitors
  • Cadonilimab
  • +2 more
  • (no location specified)
Jun 1, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Lung Cancer Trial (Cadonilimab)

Not yet recruiting
  • Lung Cancer
  • Cadonilimab
  • (no location specified)
Mar 23, 2023

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • cadonilimab
  • +4 more
  • (no location specified)
Apr 20, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial in Guangzhou (Cadonilimab, Lenvatinib)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Cetntre
Apr 9, 2023

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Cadonilimab
  • Stereotactic body radiotherapy
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

Not yet recruiting
  • Pleural Mesothelioma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 3, 2023

dMMR Colorectal Cancer Trial in Beijing (Cadonilimab)

Recruiting
  • dMMR Colorectal Cancer
  • Cadonilimab
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Bladder Cancer Trial in Tianjin (Cadonilimab)

Recruiting
  • Bladder Cancer
  • Cadonilimab
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 23, 2023

Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

Not yet recruiting
  • Gastric Cancer
  • S-1, Oxaliplatin, Cadonilimab
  • (no location specified)
Jul 10, 2023

Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Apr 7, 2023

Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)

Recruiting
  • Bile Duct Adenocarcinoma
  • surufatinib plus cadonilimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 15, 2023

Cervical Cancer Trial in Wuhan (Cadonilimab, Anlotinib)

Recruiting
  • Cervical Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 5, 2023

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cadonilimab+Gem/Cis)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Mar 22, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (Cadonilimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Cadonilimab
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Mar 27, 2023

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • Cadonilimab
  • +5 more
  • (no location specified)
Jul 17, 2023